echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Yuandong Bio: The application for clinical trial of biological drug EP-9001A injection was accepted

    Yuandong Bio: The application for clinical trial of biological drug EP-9001A injection was accepted

    • Last Update: 2021-08-09
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On July 2, Yuandong Biological issued an announcement stating that its wholly-owned subsidiary Chengdu Youluo Biotechnology Co.


    EP-9001A injection is the company's first self-developed Class 1 biological drug.


    According to data from Minai.


    Youluo Biotechnology has completed the pharmacological research, pharmacological and toxicological research and clinical trial design of EP-9001A injection, submitted the IND to the Food and Drug Administration and received the formal acceptance (acceptance number: CXSL2101166 country), and the proposed indications are For bone metastasis, cancer pain, no similar product has been approved for marketing at home and abroad


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.